R
Ron Bruehlman
Ron Bruehlman
About
Detail
Senior Advisor to CEO
Ridgefield, Connecticut, United States
Senior financial executive with extensive leadership experience in multiple industries and with both public and private companies.
Currently EVP and interim CFO of IQVIA, an S&P500 company and leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.
Board member and chairman of audit committee of Atotech Ltd., a private equity owned global leader in surface finish solutions.
Served for 5+ years as SVP and CFO of IMS Health, a $3.2B provider of information, services, and technology to the global healthcare industry.
Previously served in various senior roles with United Technologies, a $60B global provider of high technology products and services to the building and aerospace industries.
Expertise in general financial management, financial planning/analysis, investor relations, mergers and acquisitions, corporate strategy, treasury, capital markets, and manufacturing and service operations.
Experience includes:
Private/public company CFO experience (led IMS IPO in 2014) and currently EVP and Interim CFO of IQVIA.
Executed $25B merger of equals with Quintiles Transnational in 2016
CFO of $15B global manufacturing division of public company.
Substantial international experience, including Paris-based EMEA region CFO role
Extensive interaction with security analyst and banking communities through
- CFO of IMS Health
- leadership of UTC investor relations
- leadership of UTC global strategy and development
- capital markets management in UTC Treasury
Strong FP&A and operations finance background in manufacturing and service businesses at both the divisional and corporate levels
Board member and Audit Committee chairman for publicly traded company in which UTC owned a non-controlling interest.
Chairman of Board of Q-Squared Solutions, a joint venture between IQVIA Inc. and Quest Diagnostics, the second largest global provider of laboratory services for clinical trials.
Specialties: General financial management
Financial planning and analysis
Investor relations
Mergers and acquisitions
Strategy
Capital markets
Treasury
International business
Manufacturing and service operations finance